Hear In Private Practice

by Brian Fligor, PhD Last July, HHTM ran an opinion piece called “Ringing True: Why Audiology Can’t Crack Tinnitus.” It caught my attention since 90 percent of my case load and my junior associate’s involves tinnitus. It’s challenging work, but highly gratifying, particularly with the introduction of some groundbreaking, FDA-approved technology called Lenire. (“len-ear.”) As the aforementioned article correctly stated,

This article addresses the most frequently asked questions about Real Ear-to-Coupler Difference (RECD), with a focus on adult hearing aid fittings. The answers are provided by Dr. Sherman Lord, Au.D., the National Clinical Trainer for e3 Diagnostics. Please note that the discussion of RECD in this article may not apply to all hearing aid verification systems. For specific information regarding

Based on responses from 28 hearing care experts, Apple’s entry into hearing health presents immediate practice implications and long-term industry considerations. While 89% believe this will increase public awareness about hearing health, practitioners are divided on how it will affect patient flow and practice dynamics. This comprehensive analysis combines expert insights with practical implications for hearing care practices. Current Industry

Amy Meservey, Training Manager at e3 Diagnostics, has lived with hearing loss her entire life. Deaf in her right ear and with moderate-to-severe hearing loss in her left, her condition resulted from her mother contracting rubella during pregnancy. Diagnosed at around 4 or 5 years old, Amy began using a hearing aid in her left ear at age 30.  This

This article discusses the Audiology Crisis and the GSI AMTAS as one potential solution through questions answered by Tony Lombardo, Clinical Application Specialist, and Laura Prigge, Manager of Clinical Education and Training at Grason-Stadler.  Q1: What is the audiology crisis, and what are its primary causes? Prigge: The audiology crisis refers to the growing gap between the increasing demand for

By Becky Lansen, SVP and GM of Specialty, Health & Wellness, Synchrony Navigating hearing loss can be daunting, especially with the rise of over-the-counter (OTC) options following the FDA’s ruling in 2022, which allows consumers to buy a hearing aid without a prescription or professional fitting. The sheer variety of OTC devices, coupled with the complexity of hearing loss itself,

by Brian Taylor, AuD, Signia Think back to when you last studied mathematics and recall the transitive property. If A equals B and B equals C, then A equals C. In audiology, as researchers continue to explore the relationship between hearing loss (A) and cognitive decline (C), I’m often drawn, along with many patients, to issues of (B) –  social

by Michael Piskosz & Bill Schiffmiller Don’t worry, this isn’t another article that will barrage you with tinnitus statistics, facts, and figures. We see them non-stop and there are plenty of places to find them. Let’s be honest—these figures are nothing more than technical talking points that have very little influence on the real problem. These statistics don’t move the

by Michael Piskosz & Bill Schiffmiller An audiologist and a hearing aid user walk into a bar. They sit down, order a drink, and begin to chat about all things noise, sound, and hearing. The conversation quickly shifts to auditory healthcare, a topic both are intimately familiar with but from vastly different perspectives. Michael, the audiologist and a seasoned professional,

Audioscan recently introduced a unique over-the-counter / direct-to-consumer (OTC/DTC) device verification test suite for their Verifit2 system. Dr. John Pumford, Au.D., Director of Audiology, Education, and Clinical Research, answers key questions about this innovative tool and offers his expert perspective on the future of hearing care. What is the Audioscan OTC/ DTC test suite for Verifit2? Great question! The Audioscan